Form 4 Myomo Inc For: 26 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Myomo Inc (MYO)
Myomo Inc stock price live, this page displays NYSE MYO stock exchange data. View the MYO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Myomo Inc real time stock price chart below.
What Is the Myomo Inc Stock Price Today?
The Myomo Inc stock price today is 1.150.
What Is the Stock Symbol for Myomo Inc?
The stock symbol for Myomo Inc is "MYO."
What Stock Exchange Does Myomo Inc Trade On?
Myomo Inc is listed and trades on the NYSE stock exchange.
Is Myomo Inc a Good Stock to Buy?
Determining whether Myomo Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MYO quote. (ISIN: US62857J2015)
What Is the Myomo Inc Stock Price Today?
The Myomo Inc stock price today is 1.150.
What Is the Stock Symbol for Myomo Inc?
The stock symbol for Myomo Inc is "MYO."
What Stock Exchange Does Myomo Inc Trade On?
Myomo Inc is listed and trades on the NYSE stock exchange.
Is Myomo Inc a Good Stock to Buy?
Determining whether Myomo Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MYO quote. (ISIN: US62857J2015)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.030
1.170
52 wk Range
0.605
2.380
MYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0301.170
52 wk Range
0.6052.380
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MYO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
4.420
Upside
+284.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Form 144 MYOMO For: 12 June
- Investing.com
- Myomo CMO Kovelman sells $32,239 in company stock
- Investing.com
- Form 4 Myomo Inc For: 12 June
- Investing.com
- Form 4 Myomo Inc For: 26 June
- Investing.com
- Form 144 MYOMO For: 12 June
- Investing.com
- Form 4 Myomo Inc For: 12 June
- Investing.com
- Myomo CCO Mitchell Micah sells $77,688 in stock
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.420
(+284.35% Upside)
Myomo Inc Earnings Call Summary for Q1/2026
- Myomo Q1 2026 revenue hit $10.1M (+3% YoY), beating forecast by 9.31%; EPS of -$0.07 topped estimates of -$0.12 by 41.67%
- Delivered 172 MyoPro units with 9% YoY price increase; gross margin improved to 68.2% from 67.2% year-ago, reflecting operational gains
- Stock declined 2.98% post-earnings despite beat, extending 75% twelve-month decline; $31.4M market cap reflects investor caution
- Q2 2026 guidance projects $10.3M-$10.8M revenue (7-12% YoY growth); gross margins expected to improve YoY but decline sequentially
- CEO Gudonis highlighted MyoConnect program and international expansion as growth drivers; risks include net losses and Medicare reimbursement dependency
Last Updated: 2026-05-13, 10:24 p/m
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
-0.07 / -0.12
Revenue / Forecast
10.1M / 9.24M
Compare MYO to Peers and Sector
Metrics to compare | MYO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMYOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.6x | −3.8x | −0.4x | |
PEG Ratio | 0.02 | −0.33 | 0.00 | |
Price/Book | 4.4x | 5.1x | 2.6x | |
Price / LTM Sales | 1.0x | 3.3x | 3.0x | |
Upside (Analyst Target) | 191.3% | 65.0% | 49.1% | |
Fair Value Upside | Unlock | 13.4% | 6.3% | Unlock |
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Myomo (MYO) Stock Price Today?
The Myomo stock price today is 1.150 USD.
What Stock Exchange Does Myomo Trade On?
Myomo is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Myomo?
The stock symbol for Myomo is "MYO."
What Is the Myomo Market Cap?
As of today, Myomo market cap is 44.630M USD.
What Is Myomo's Earnings Per Share (TTM)?
The Myomo EPS (TTM) is -0.392.
When Is the Next Myomo Earnings Date?
Myomo will release its next earnings report on Aug 11, 2026.
From a Technical Analysis Perspective, Is MYO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Myomo Stock Split?
Myomo has split 1 times.
How Many Employees Does Myomo Have?
Myomo has 195 employees.
What is the current trading status of Myomo (MYO)?
As of Jul 06, 2026, Myomo (MYO) is trading at a price of 1.150 USD, with a previous close of 1.030 USD. The stock has fluctuated within a day range of 1.030 USD to 1.170 USD, while its 52-week range spans from 0.605 USD to 2.380 USD.
What Is Myomo (MYO) Price Target According to Analysts?
The average 12-month price target for Myomo is 4.420 USD, with a high estimate of 10 USD and a low estimate of 1.1 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +284.35% Upside potential.
What Is the MYO Premarket Price?
MYO's last pre-market stock price is 1.080 USD. The pre-market share volume is 6,830.000, and the stock has decreased by 0.050, or 4.850%.
What Is the MYO After Hours Price?
MYO's last after hours stock price is 1.152 USD, the stock has decreased by 0.002, or 0.130%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.